Lanifibranor efficacy in NASH evident in diabetics and non-diabetics

The efficacy of lanifibranor in reducing histological markers of non-alcoholic steatohepatitis (NASH) is comparable in patients with and without type 2 diabetes (T2D), according to the phase IIb NATIVE study presented as a poster at AASLD 2020.

Adherence to Mediterranean diet lowers risk of progression to late AMD, large drusen
Closer adherence to a Mediterranean-type diet appears to reduce the risk of progression to large drusen and to late age-related macular degeneration (AMD), with the signal being greater for geographic atrophy (GA) than neovascular AMD, as shown in a retrospective analysis of two controlled clinical trials cohorts, namely Age-Related Eye Disease Study (AREDS) and AREDS2.

New Molecule

2 New

New Formulation

1 New

New Brand

18 New

Color 1
Color 2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in